Continuum Advisory’s Mesa Laboratories MLAB Stock Holding History

Continuum Advisory’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-33	Closed	-$3.87K	–	1737
2024 Q1	$3.87K	Buy	+33	New	+$3.33K	﹤0.01%	1121

Other funds holding MLAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Continuum Advisory's MLAB Position: Q2 2024 in Review

Continuum Advisory sold out of Mesa Laboratories (MLAB) in Q2 2024, closing a stake of 33 shares — an estimated $3.87K sold.

Continuum Advisory first reported a position in MLAB in Q1 2024 and held it in 1 quarter. The position peaked at $3.87K in Q1 2024. 154 funds tracked by Wall St. Rank hold MLAB as of Q2 2024.

Continuum Advisory reported no remaining Mesa Laboratories position as of Q2 2024 after selling out during the quarter.
Continuum Advisory sold 33 Mesa Laboratories shares in Q2 2024, an estimated $3.87K.
Continuum Advisory first reported a position in Mesa Laboratories in Q1 2024 and held it in 1 quarter.
Continuum Advisory's Mesa Laboratories position peaked at $3.87K in Q1 2024.
154 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2024.

Based on Continuum Advisory's 13F filing for Q2 2024, filed 19 Jul 2024.